Narrative review / 2008
A review discusses synthetic SERMs alongside emerging research on soy phytoestrogens as potential natural SERMs for breast cancer protection.
This review examines the development and clinical roles of synthetic selective estrogen receptor modulators (SERMs), tamoxifen and raloxifene, in breast cancer treatment and prevention. It notes that lower rates of breast cancer are observed in regions such as Asia where diets are high in soy and low in fat. The article highlights emerging research on soy phytoestrogens and their metabolites as potential natural SERMs and evaluates their similarities and differences compared to synthetic SERMs.
- Study type
- Narrative review
- Who was studied
- Women with or at risk for breast cancer
- What was measured
- Breast cancer prevention and treatment, comparison of SERMs and phytoestrogens
THE PAPER
Selective estrogen receptor modulators and phytoestrogens.
Oseni T, Patel R, Pyle J, Jordan VC. Planta Med, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.